Member Info for Lionel1

Unlocking the Code: CYP2C19 Pharmacogenomics to Guide Clopidogrel Therapy

Emma Groves, NHS North East & Yorkshire Genomic Medicine Service Alliance Pharmacy Lead

Patrick Mok, Lead Stroke Pharmacist, Doncaster & Bassetlaw

This session will provide an update on the latest advances in genomic medicine and the impact on medicines optimisation. We will

also explore the local implementation of CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient

ischaemic attack at Doncaster and Bassetlaw, as part of a national pilot to inform future implementation of the NICE Diagnostics

guidance [DG59].

https://www.events.england.nhs.uk/uploads/entity/419904/future-of-hospital-pharmacy-conference-agenda-4th-december-67373887c1353.pdf

Https://www.doncasterfreepress.co.uk/news/doncaster-and-bassetlaw-teaching-hospitals-selected-for-national-pilot-on-genetic-testing-for-stroke-patients-4905460

Dr John McDermott, NIHR Doctoral Research Fellow at the University of Manchester said:

"This award is a testament to the hard work of so many people from across the University and at the hospital. With the genedrive technology set to be rolled out across the country as part of PALOH-UK, we're excited to see how the impact of this intervention will continue to grow."

https://www.bbpmedia.co.uk/news/education/the-university-of-manchester-celebrates-double-win.html

Https://www.marketscreener.com/quote/stock/MICROBIX-BIOSYSTEMS-INC-1410740/news/Microbix-Biosystems-Assisting-EMQN-with-Novel-Genetic-Test-EQA-Program-48557141/

Agree Stephen , in a way he insulted the investors :-(

I have received email today to vote , I agreed with the board proposal for all except Russ Shaw , voted against this fella, he needs to go..

I think they are in Performance Data submission phase at the moment ..

“ Whilst scheduled for a maximum of 18 months, performance data can be submitted to the NICE EVA Evidence

Generation team at an earlier point if the team believes the evidence generation requirements have been

successfully fulfilled. Performance data generated during the programme is also expected to contribute towards

clinical performance data requirements for FDA as part of planned De novo submission process required for

commercial entry into the U.S.”

No one ramping , and there is nothing to ramp anyway , all the facts are already listed, Whoever left on this board are here from long time , sadly some of them are with very high average, and other side scavengers like you as soon they sold they come here write some nonsense , I would never go on a board write something if I sold out . Now stfu and board your cruise with 2% profit you made other day .. All IMHO

What a sad individual and miserable person you are Popeye , I am sorry for the people around you… get well soon..

All IMHO

I thought this was a sell from Monday ??? Late print ?

Very good watch if you have time , especially the Q&A towards the end . Listen to Videha why they chosen POC test over the lab test .

https://youtu.be/3isEHPpjFzY?si=t20vzawRAos_Jdmy

And also Cyp2c19 test … did you miss the important slide on the presentation where it says .. Both of our PGx tests been developed “With the NHS and for the NHS” ??

@Garden do you think NHS trialing out the RnR1 test @14 hospitals for fun ???? lol you looks desperate:-)

@Gardengecko so you are as EC , you also know nothing about the company plans and speculating nonsense about placing , working hard for your short :-) , most people here been thru all this nonsense over and over again ..

@winni , are you talking about gardengecko and popeye?

Too many unsolicited advice’r/s this morning , what’s going on ??

Genedrive featured in this American blog .

Https://americanpharmacogenomicsassociation.com/gated-content/exploring-the-business-of-pharmacogenomics/

@Popeye , Could have been better but not bad .. facts still same , happy with the progress they made and I know where it is going ..

@GardenGecko , posting opinion is different than posting drivel , did you see Papaya’s posting history ?? I do agree the presentation is not upbeat but I do also sense they are getting very close to meaningful sales and self sustainability.. wait and see as soon as @Popeye buy some how will ramp this to the moon :-) .